Karyopharm Therapeutics, Inc. (KPTI)
0.0389
-0.02
(-29.14%)
USD |
NASDAQ |
Nov 09, 16:00
0.0336
-0.01
(-13.62%)
After-Hours: 18:10
Karyopharm Therapeutics Gross Profit (Annual) : 139.82M for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 139.82M |
| December 31, 2024 | 138.89M |
| December 31, 2023 | 140.56M |
| December 31, 2022 | 151.24M |
| December 31, 2021 | 205.63M |
| December 31, 2020 | 104.41M |
| December 31, 2019 | 37.51M |
| December 31, 2018 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| December 31, 2012 | 0.512M |
| December 31, 2011 | 0.069M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Heron Therapeutics, Inc. | 113.56M |
| Tonix Pharmaceuticals Holding Corp. | 4.542M |
| Minerva Neurosciences, Inc. | -0.0054M |
| Corbus Pharmaceuticals Holdings, Inc. | -0.233M |
| Ocugen, Inc. | 2.024M |